Rogério Vivaldi Coelho
Fortune : 885 622 $ au 31/10/2026
Fortune : 885 622 $ au 31/10/2026
Dr. Rogério Vivaldi Coelho is an Independent Director at Viatris, Inc. He is on the Board of Directors at Viatris, Inc. Dr. Vivaldi Coelho was previously employed as an Independent Director by Crinetics Pharmaceuticals, Inc., a Chief Executive Officer by Sigilon Therapeutics, Inc., a Chief Global Therapeutics Officer & Executive VP by Bioverativ, Inc., a Chief Commercial Officer by Spark Therapeutics, Inc., a President, Chief Executive Officer & Director by Minerva Neurosciences, Inc., and a Senior Vice President & Head-Rare Diseases by Genzyme Corp.
He also served on the board at Mind-NRG SARL. He received his MBA from COPPEAD Graduate School of Business and a doctorate degree from Federal University of Rio de Janeiro.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 46 526 ( 0% ) | 885 622 $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIATRIS INC. | Directeur/Membre du Conseil | 03/06/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| CRINETICS PHARMACEUTICALS | Directeur/Membre du Conseil | 01/09/2026 |
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2018 |
| SPARK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2015 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MINERVA NEUROSCIENCES, INC. | Directeur Général | 20/11/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Federal University of Rio de Janeiro
Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
COPPEAD Graduate School of Business
COPPEAD Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national